Lung health in a changing world

Peters, Matthew J; Bourke, Jane E

doi:10.5694/mja17.00853

Topics

Respiratory tract diseases

Environment and public health

Pharmaceutical preparations

Medical genetics

Respiratory health is threatened by changes to our climate and environment — but there is also good news

This respiratory medicine-themed issue of the MJA coincides with the meeting in Sydney this month of the Asia Pacific Society of Respirology, which has the title, “Lung health in a changing world”. It provides us with an opportunity to reflect on some of the major factors affecting respiratory health in Australia and its near neighbours, including questions discussed in recent issues of this Journal.

1 Macquarie University, Sydney, NSW
2 Concord Repatriation General Hospital, Sydney, NSW
3 Biomedicine Discovery Institute, Monash University, Melbourne, VIC

Correspondence: matthew.peters@mq.edu.au

Competing interests:

No relevant disclosures.

1. Witt C, Schubert AJ, Jehn M, et al. The effects of climate change on patients with chronic lung disease: a systematic literature review. Dtsch Arztebl Int 2015; 112: 878-883.
2. Collaco JM, McGready J, Green DM, et al. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PLoS One 2011; 6: e27784.
3. Parameswaran U, Baird RW, Ward LM, Currie BJ. Melioidosis at Royal Darwin Hospital in the big 2009–2010 wet season: comparison with the preceding 20 years. Med J Aust 2012; 196: 345-348. <MJA full text>
4. Stewart JD, Smith S, Hanson J. Melioidosis in Far North Queensland is not correlated with severe weather events. Med J Aust 2017; 207: 394.
5. Australian Government, Office of Northern Australia. Our north, our future: white paper on developing northern Australia. Canberra: Commonwealth of Australia, 2015. http://northernaustralia.gov.au/files/files/NAWP-FullReport.pdf (accessed Sept 2017).
6. Lindstrom SJ, Silver JD, Sutherland MF, et al. Thunderstorm asthma outbreak of November 2016: a natural disaster requiring planning. Med J Aust 2017; 207: 235-237. <MJA full text>
7. Sutherland MF, Le Portelli E, Collins AL, et al. Patients with thunderstorm asthma or severe asthma in Melbourne: a comparison. Med J Aust 2017; 207: 434-435.
8. Ren C, Tong S. Health effects of ambient air pollution – recent research development and contemporary methodological challenges. Environ Health 2008; 7: 56.
9. World Health Organization. Ambient air pollution: a global assessment of exposure and burden of disease. Geneva: WHO, 2016. http://www.who.int/phe/publications/air-pollution-global-assessment/en/ (accessed Aug 2016).
10. Zosky GR, Hoy RF, Silverstone EJ, et al. Coal workers’ pneumoconiosis: an Australian perspective. Med J Aust 2016; 204: 414-418. <MJA full text>
11. Olsen NJ, Franklin PJ, Reid A, et al. Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation. Med J Aust 2011; 195: 271-274. <MJA full text>
12. Hoy RF, Brims F. Occupational lung diseases in Australia. Med J Aust 2017; 207: 443-448.
13. Musk AW, de Klerk N, Brims FJ. Mesothelioma in Australia: a review. Med J Aust 2017; 207: 449-452.
14. Millard J, Moore DAJ. Multidrug resistant tuberculosis. BMJ 2015; 350: h882.
15. Dowling HF, Lepper MH. Effect of antibiotics (penicillin, aureomycin, and terramycin) on fatality rate and incidence of complications in pneumococcic pneumonia: comparison with other methods of therapy. Am J Med Sci 1951; 222: 396-402.
16. Sidjabat HE, Paterson DL. Multidrug-resistant Escherichia coli in Asia: epidemiology and management. Expert Rev Anti Infect Ther 2015; 13: 575-591.
17. Charu V, Zeger S, Gog J, et al. Human mobility and the spatial transmission of influenza in the United States. PLoS Comput Biol 2017; 13: e1005382.
18. Australian Government, Department of Foreign Affairs and Trade. Composition of Australia’s trade in services with our major trading partners: 2006 to 2016. http://dfat.gov.au/about-us/publications/Documents/australias-trade-in-services-2006-2016.pdf (accessed Aug 2017).
19. Australian Institute of Health and Welfare. National Drug Strategy Household Survey (NDSHS) 2016 — key findings. https://www.aihw.gov.au/reports/illicit-use-of-drugs/ndshs-2016-key-findings/contents/tobacco-smoking (accessed Aug 2017).
20. Soneji S, Barrington-Trimis JL, Wills TA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr 2017; 171: 788-797.
21. Bonevski B, Borland R, Paul CL, et al. No smoker left behind: it’s time to tackle tobacco in Australian priority populations. Med J Aust 2017; 207: 141-142. <MJA full text>
22. Freeman B. Challenging how tobacco is sold in Australia. Med J Aust 2017; 207: 417-418.
23. MacKenzie R, LeGresley E, Daube M. Legal does not mean unaccountable: suing tobacco companies to recover health care costs. Med J Aust 2017; 207: 419-421.
24. O’Donnell DE, Ciavaglia CE, Neder JA. When obesity and chronic obstructive pulmonary disease collide: physiological and clinical consequences. Ann Am Thorac Soc 2014; 11: 635-644.
25. Accurso FJ, Rowe SM, Clancy JP, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med 2010; 363: 1991-2003.
26. Zhang C, Wei B, Li P, et al. Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs. PLoS One 2017; 12: e0173524.
27. Berg JS, Khoury MJ, Evans JP. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med 2011; 13: 499-504.

Online responses are no longer available. Please refer to our instructions for authors page for more information.